MAPT and Alzheimer disease: During the progression of AD, microglia are abnormally activated in response to external signals such as protein aggregates, such as Aβ and tau, or cellular damage signals, and may transition into various states, including disease-associated microglia (DAMs) and microglial neurodegenerative phenotype (MGnD).